Well I think just knowing that ACTC has the potential to grow new and disease-free organs from stem cells to replace organs that go bad in humans is worth a heck of alot more than a measley $19 million market cap. That technology alone is worth billions and billions and sure, it's not going to happen tomorrow, but investing now (especially if the company no longer has to sell stock to raise cash) just might give people the opportunity to look back and laugh profusely. I'll take that chance and be confident in my thinking that the current valuation is simply stupid. No doubt that management has to make the right decisions along the way, but again, why sell ACTC if the company isn't selling stock ?
News 
Market Data 
Discover 
AI
